Your browser doesn't support javascript.
loading
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib.
Ali, Siraj M; Alpaugh, R Kathy; Buell, Jamie K; Stephens, Philip J; Yu, Jian Qin Michael; Wu, Hong; Hiemstra, Christine N; Miller, Vincent A; Lipson, Doron; Palmer, Gary A; Ross, Jeffrey S; Cristofanilli, Massimo.
Afiliação
  • Ali SM; Foundation Medicine, Inc, Cambridge, MA.
  • Alpaugh RK; Department of Pathology.
  • Buell JK; Foundation Medicine, Inc, Cambridge, MA.
  • Stephens PJ; Foundation Medicine, Inc, Cambridge, MA.
  • Yu JQ; Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, PA.
  • Wu H; Department of Pathology.
  • Hiemstra CN; Foundation Medicine, Inc, Cambridge, MA.
  • Miller VA; Foundation Medicine, Inc, Cambridge, MA.
  • Lipson D; Foundation Medicine, Inc, Cambridge, MA.
  • Palmer GA; Foundation Medicine, Inc, Cambridge, MA.
  • Ross JS; Foundation Medicine, Inc, Cambridge, MA; Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY.
  • Cristofanilli M; Department of Pathology. Electronic address: Massimo.Cristofanilli@Jefferson.edu.
Clin Breast Cancer ; 14(1): e14-6, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24201163
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Inibidores de Proteínas Quinases / Neoplasias Inflamatórias Mamárias / Receptores ErbB / Mutação Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Inibidores de Proteínas Quinases / Neoplasias Inflamatórias Mamárias / Receptores ErbB / Mutação Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article